These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38730728)

  • 1. The Current Role of Radiation in the Management of Cholangiocarcinoma-A Narrative Review.
    Verma S; Grindrod N; Breadner D; Lock M
    Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs.
    Spolverato G; Glavas D; Hewitt DB; Brown ZJ; Capelli G; Bergamo F; Rizzato MD; Pawlik TM
    Expert Opin Pharmacother; 2022 Mar; 23(4):473-481. PubMed ID: 34964678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
    Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
    Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in targeted therapy of cholangiocarcinoma.
    Li Y; Yu J; Zhang Y; Peng C; Song Y; Liu S
    Ann Med; 2024 Dec; 56(1):2310196. PubMed ID: 38359439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer review: Cholangiocarcinoma.
    Ghouri YA; Mian I; Blechacz B
    J Carcinog; 2015; 14():1. PubMed ID: 25788866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate.
    Le VH; O'Connor VV; Li D; Melstrom LG; Fong Y; DiFronzo AL
    J Surg Oncol; 2021 Jan; 123(1):164-171. PubMed ID: 32974932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential targeted therapy for liver fluke associated cholangiocarcinoma.
    Vaeteewoottacharn K; Seubwai W; Bhudhisawasdi V; Okada S; Wongkham S
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):362-70. PubMed ID: 24408866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma.
    Lu X; Green BL; Xie C; Liu C; Chen X
    JHEP Rep; 2023 Jul; 5(7):100723. PubMed ID: 37229173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option.
    Melandro F; Nasto RA; Ginesini M; Balzano E; Bindi ML; Ghinolfi D; Lai Q
    Chin Clin Oncol; 2023 Apr; 12(2):13. PubMed ID: 37038053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of cholangiocarcinoma.
    Loeuillard E; Conboy CB; Gores GJ; Rizvi S
    JHEP Rep; 2019 Oct; 1(4):297-311. PubMed ID: 32039381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in the use of targeted therapies for the treatment of cholangiocarcinoma.
    Lodl E; Ramnaraign B; Sahin I; Wheeler S
    J Oncol Pharm Pract; 2023 Jul; 29(5):1206-1217. PubMed ID: 37097888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma.
    Bath NM; Pawlik TM
    Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current Studies and Evidence in Cholangiocarcinoma].
    Zimpel C; Mitzlaff K; Jasper NA; Marquardt JU
    Zentralbl Chir; 2022 Aug; 147(4):389-397. PubMed ID: 35863357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers.
    Chen R; Zheng D; Li Q; Xu S; Ye C; Jiang Q; Yan F; Jia Y; Zhang X; Ruan J
    Cancer Lett; 2022 Oct; 546():215853. PubMed ID: 35921970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatment of advanced or recurrent biliary tract cancer.
    Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
    Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new insight of treatment in Cholangiocarcinoma.
    Li Y; Song Y; Liu S
    J Cancer; 2022; 13(2):450-464. PubMed ID: 35069894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches.
    Khosla D; Misra S; Chu PL; Guan P; Nada R; Gupta R; Kaewnarin K; Ko TK; Heng HL; Srinivasalu VK; Kapoor R; Singh D; Klanrit P; Sampattavanich S; Tan J; Kongpetch S; Jusakul A; Teh BT; Chan JY; Hong JH
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.